about
LINE retrotransposon RNA is an essential structural and functional epigenetic component of a core neocentromeric chromatinFOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosisMechanisms of Histone Deacetylase Inhibitor-Regulated Gene Expression in Cancer CellsVariable and hierarchical size distribution of L1-retroelement-enriched CENP-A clusters within a functional human neocentromereThe intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent mannerBAC-based PCR fragment microarray: high-resolution detection of chromosomal deletion and duplication breakpoints.Neocentromeres: new insights into centromere structure, disease development, and karyotype evolutionTransketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells.A beacon of hope in stroke therapy-Blockade of pathologically activated cellular events in excitotoxic neuronal death as potential neuroprotective strategies.Dual Targeting of Bromodomain and Extraterminal Domain Proteins, and WNT or MAPK Signaling, Inhibits c-MYC Expression and Proliferation of Colorectal Cancer Cells.PR55α-containing protein phosphatase 2A complexes promote cancer cell migration and invasion through regulation of AP-1 transcriptional activity.Molecular imaging of death receptor 5 occupancy and saturation kinetics in vivo by humanized monoclonal antibody CS-1008.Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent manner.Csk-homologous kinase (Chk/Matk): a molecular policeman suppressing cancer formation and progression
P50
Q21145016-5E199302-D4CA-4D81-9BEC-BE5590C96DF0Q24567994-8C5BDA8E-05C5-490B-8276-B7D21206BAABQ27015931-31F4CD79-100F-46BE-AE55-445EA0365657Q28292622-8C6949C1-DDA8-48F4-8035-A99328031E29Q34139192-772C2ECE-16F9-4EB6-8D73-0376EFD1AABCQ34411721-DABC1724-A34F-4ED4-9A65-20AED85C179BQ34746589-0069BA5F-D8FB-404E-B56F-1CB19053A4A2Q35932960-779F04CF-813D-473C-90B4-A275E8A117ECQ38743180-F1BFE8F7-2F9E-4308-9A64-77F9403C923AQ38785795-C7682528-06D2-4CA4-8A34-7B7EC4EFD44BQ39015110-DF53B9B6-AAAD-4AEF-ADD0-952B84B55D15Q39094599-2FDB81BA-F2AC-4A64-8000-76342549DAF7Q42426446-EBE2456E-E3BE-46A3-B58F-AE54F0191CEEQ48764064-82146A26-B1B3-4930-A9CA-895D373E7C48Q55030126-7FF6C019-81D8-4816-95A8-24A15641C523Q58134756-7E69ED68-0E60-4EEC-9363-BD05BAEC8146
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Anderly C. Chueh
@ast
Anderly C. Chueh
@en
Anderly C. Chueh
@es
Anderly C. Chueh
@nl
type
label
Anderly C. Chueh
@ast
Anderly C. Chueh
@en
Anderly C. Chueh
@es
Anderly C. Chueh
@nl
prefLabel
Anderly C. Chueh
@ast
Anderly C. Chueh
@en
Anderly C. Chueh
@es
Anderly C. Chueh
@nl
P1053
D-8615-2015
N-2794-2017
P106
P1153
8416091900
P1960
bPTz6DAAAAAJ
P2798
P31
P3829
P496
0000-0003-1140-5516